149 related articles for article (PubMed ID: 8733693)
1. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD.
Puppo F; Brenci S; Ghio M; Bignardi D; Contini P; Bacigalupo A; Van Lint MT; Scudeletti M; Ferrone S; Indiveri F
Bone Marrow Transplant; 1996 May; 17(5):753-8. PubMed ID: 8733693
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease.
Liem LM; Koelman CA; Doxiadis II; van Houwelingen JC; Goulmy E; Claas FH
Bone Marrow Transplant; 1997 Aug; 20(3):227-34. PubMed ID: 9257891
[TBL] [Abstract][Full Text] [Related]
3. Soluble interleukin 2 receptors in patients after bone marrow transplantation.
Siegert W; Josimovic-Alasevic O; Schwerdtfeger R; Baurmann H; Schmidt CA; Musch R; Schmid HJ; Hartmann R; Henze G; Huhn D
Bone Marrow Transplant; 1990 Aug; 6(2):97-101. PubMed ID: 2207458
[TBL] [Abstract][Full Text] [Related]
4. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
[TBL] [Abstract][Full Text] [Related]
6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
7. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.
Passweg JR; Tiberghien P; Cahn JY; Vowels MR; Camitta BM; Gale RP; Herzig RH; Hoelzer D; Horowitz MM; Ifrah N; Klein JP; Marks DI; Ramsay NK; Rowlings PA; Weisdorf DJ; Zhang MJ; Barrett AJ
Bone Marrow Transplant; 1998 Jan; 21(2):153-8. PubMed ID: 9489632
[TBL] [Abstract][Full Text] [Related]
9. Correlation of low histidine rich glycoprotein plasma levels with the occurrence of acute graft-versus-host disease after allogeneic bone marrow transplantation.
Mauz-Körholz C; Körholz D; Burdach S
J Lab Clin Med; 1995 Aug; 126(2):144-50. PubMed ID: 7636387
[TBL] [Abstract][Full Text] [Related]
10. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
[TBL] [Abstract][Full Text] [Related]
12. [Determination of soluble HLA class I molecules in children in bone marrow transplantation].
Sedivá A; Starý J; Hromadníková I; Skalická A; Ghio M
Cas Lek Cesk; 2000 Oct; 139(20):630-4. PubMed ID: 11192758
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
Russell CA; Heilmann C; Madsen HO; Vindeløv LL
Bone Marrow Transplant; 2001 May; 27(9):949-58. PubMed ID: 11436105
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary study of HLA haplotype matched and T-cell undepleted allogeneic bone marrow transplantation for treatment of leukemia].
Ji S; Chen H; Wang H
Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):408-10. PubMed ID: 11718090
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
16. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
17. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
[TBL] [Abstract][Full Text] [Related]
18. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
Bacigalupo A; Oneto R; Bruno B; Lamparelli T; Gualandi F; Bregante S; Raiola AM; Di Grazia C; Dominietto A; Lombardi A; Frassoni F; Van Lint MT
Bone Marrow Transplant; 2001 Dec; 28(11):1041-5. PubMed ID: 11781614
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-host disease following allogeneic bone marrow transplantation.
Yoshikawa S; Akao Y; Hiraiwa A; Sao H; Yamauchi T; Tahara T; Yoshikawa H; Matsuyama K; Kimura S; Kitayama S
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():509-18. PubMed ID: 6394814
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]